title: Increased urinary NAG excretion in hypertensives can decline with antihypertensive treatment.
authors.forename: S
authors.initials: S
authors.lastname: Turkmen
authors.forename: H
authors.initials: H
authors.lastname: Uzun
authors.forename: S
authors.initials: S
authors.lastname: Aydin
authors.forename: R
authors.initials: R
authors.lastname: Ozaras
authors.forename: V
authors.initials: V
authors.lastname: Tahan
authors.forename: G E
authors.initials: GE
authors.lastname: Oztekin
authors.forename: S
authors.initials: S
authors.lastname: Dondurmaci
mesh_terms: D000117:Acetylglucosamine / Q000652:urine*; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000652:urine; D003404:Creatinine / Q000097:blood; D003971:Diastole; D005260:Female; D017328:Fosinopril / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D013599:Systole
chemical_list: D000959:Antihypertensive Agents; D015415:Biomarkers; D003404:Creatinine; D017328:Fosinopril; D011188:Potassium; D000117:Acetylglucosamine